Table 2.
Before PSM (1:4 age–sex matching) | After 1:2 PSM | |||
---|---|---|---|---|
Non-AS n = 24,012 | ASn = 6,003 | Non-AS n= 11,392 | ASn = 5,696 | |
Follow up person months | 1,913,078 | 471,482 | 905,332 | 447,988 |
New fibromyalgia case | 607 | 239 | 356 | 232 |
Incidence rate*(95% CI) | 0.32 (0.29–0.34) | 0.51 (0.45–0.58) | 0.39 (0.35–0.44) | 0.52 (0.46–0.59) |
Crude Relative risk (95% CI) | Reference | 1.60 (1.37–1.85) | Reference | 1.32 (1.12–1.55) |
Incidence rate, per 1,000 person-months.